Finance

Beta
Lists
IVA:NASDAQ
Inventiva SA - ADR
$3.41
-2.57%
(-0.090) 1D
Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IVA...
Open
$3.44
High
$3.58
Low
$3.35
Mkt. cap
777.80M
Avg. vol.
800.40K
Volume
1.34M
52-wk high
$7.98
52-wk low
$2.85
EPS
-$2.16
Beta
0.64
Shares outstanding
236.28M
No. of employees
73
Open
$3.44
High
$3.58
Low
$3.35
Mkt. cap
777.80M
Avg. vol.
800.40K
Volume
1.34M
52-wk high
$7.98
52-wk low
$2.85
EPS
-$2.16
Beta
0.64
Shares outstanding
236.28M
No. of employees
73
News stories
From sources across the web
About Inventiva SA - ADR
CEO-
Employees73
Founded2011
Headquarters-
SectorBiotechnology
Websiteinventivapharma.com
Analyst ratings
Based on 9 analysts giving stock ratings to IVA in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for IVA in the last 3 months.
Highest
Current $3.41
$26.00 (+662.46%)
Average
$15.75 (+361.88%)
Lowest
$10.00 (+193.26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Yee
UBS
Buy
Initiated
$12.00
+251.9%
06/12/2026
Ritu Baral
TD Cowen
Buy
Maintained
$10.00
+193.3%
06/09/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$26.00
+662.5%
06/08/2026
Eliana Merle
Barclays
Buy
Maintained
$18.00
+427.9%
06/04/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
-
-
05/29/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
$11.00
+222.6%
05/27/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
$20.00
+486.5%
04/02/2026
Annabel Samimy
Stifel Nicolaus
Buy
Maintained
$15.00
+339.9%
03/31/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$14.00
+310.6%
03/31/2026
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
$24.00
+603.8%
01/28/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.80M
2.80M
575.50K
575.50K
Cost of goods sold
-27.00K
-27.00K
38.00K
38.00K
Cost of revenue
-27.00K
-27.00K
38.00K
38.00K
Research and development expenses
21.44M
21.44M
20.14M
20.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.95M
6.95M
14.86M
14.86M
Operating expense
30.65M
30.65M
39.16M
39.16M
Total operating expenses
30.63M
30.63M
39.20M
39.20M
Operating income
-27.82M
-27.82M
-38.62M
-38.62M
Other non operating income
-51.33M
-51.33M
-38.58M
-38.58M
EBT including unusual items
-88.19M
-88.19M
-88.87M
-88.87M
EBT excluding unusual items
-84.54M
-84.54M
-88.45M
-88.45M
Income tax expense
-251.50K
-251.50K
262.50K
262.50K
Effective tax rate
0.29%
0.29%
-0.30%
-0.30%
Other operating expenses
1.62M
1.62M
4.16M
4.16M
Net income
-87.94M
-87.94M
-89.13M
-89.13M
Net profit margin
-3,135.15%
-3,135.15%
-15,487.05%
-15,487.05%
Earnings per share
-
-
-
-
Interest and investment income
623.00K
623.00K
849.50K
849.50K
Interest expense
-4.86M
-4.86M
-11.92M
-11.92M
Net interest expenses
-4.24M
-4.24M
-11.07M
-11.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.27M
-26.27M
-38.04M
-38.52M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of IVA
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer